Observational study evaluating the long-term safety and efficacy of avapritinib in the first-line treatment of patients with platelet-derived growth factor receptor alpha (PDGFRA) D842V-mutated gastrointestinal stromal tumour (GIST)

13/07/2021
05/03/2026
EU PAS number:
EUPAS41969
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

blu-285-1406 pass protocol v2.0.pdf

English (1.4 MB - PDF) View document
Updated protocol

BLU-285-1406 PASS Protocol v6.0.pdf

First published: 24/09/2025
English (1.3 MB - PDF) View document

BLU-285-1406 PASS Protocol v5.0.pdf

First published: 08/03/2024
English (1.14 MB - PDF) View document
Study results
Study report
Other information